RA Capital — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.
BiotechResearch Triangle Park, US
Timothy Sullivan(Director)Mark A. Velleca(Executive Officer, Director)Glenn Muir(Director)Gregory Mossinghoff(Executive Officer)Seth Rudnick(Director)Ron Laufer(Director)
Board seatPeter Kolchinsky· per SEC Form D
BiotechArlington, US
Daniel S. Grau(Executive Officer, Director)Scott L. Rakestraw(Director)
Board seatPeter Kolchinsky· per SEC Form D · $44M raise · filed Nov 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.